Brian Mandell, M.D., Ph.D.
| Appointed: |
1993 |
| Gender: |
Male |
| Languages: |
English |
Rheumatologic and Immunologic Disease
Education
Editor-in-Chief, Cleveland Clinic Journal of Medicine
Biographical Sketch
Brian Mandell, MD, PhD, is board-certified in internal medicine and rheumatology. He is Director of Scholarly Activities of the Internal Medicine Residency Program at Cleveland Clinic, and serves on the Clinic's Board of Governors, the Graduate Medical Education Council, Continuing Health Sciences Education Committee, and Education Governing Group.
Dr. Mandell is also Editor-in-Chief, Cleveland Clinic Journal of Medicine.
Professional Highlights
- Editor, Rheumatology and Allergy Sections, The Merck Manual (home and professional editions)
- Chair of Annual Scientific Meeting American College Rheumatology
- Chair of Annual American College of Physicians Annual Meeting
Education & Fellowships
| Medical School: | New York University School of Medicine, New York, NY |
|
| Internship: | Hospital of University of Pennsylvania, Internal Medicine, Philadelphia, PA |
| Residency: | Hospital of University of Pennsylvania, Internal Medicine, Philadelphia, PA |
| Fellowship: | Hospital of University of Pennsylvania, Rheumatology, Philadelphia, PA |
| Other Education: | (Doctorate) Washington University School of Medicine, St. Louis, MO |
| Other Education: | (Undergraduate) Washington University, St. Louis, MO |
Additional Training
- Stanford University Clinical Teaching Faculty Development Program
Certifications
Rheumatology
Internal Medicine
Specialty Interests
Vasculitis, gout, systemic lupus, myositis, multisystem involvement from autoimmune disease.
Awards & Honors
Cleveland Best Doctors list for many years
Professional Memberships
- Association Program Director of Internal Medicine
Specializes in Diseases and Conditions
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical education about recent trends. The collaborations are reviewed as part of the Cleveland Clinic’s procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its doctors’ connections with industry and those of their immediate family members. As of 7/30/2008, Dr. Mandell has reported the financial relationships with the companies listed below. Patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic’s policies on collaborations with industry and innovation management, go to our
Integrity in Innovation page.
Consulting. Dr. Mandell receives fees of $5,000 or more per year as a paid consultant or speaker for the following companies:
- Merck & Co. Inc. (Merck Manual)
Fiduciary Role. Dr. Mandell serves in a fiduciary capacity, such as an officer or director, for the following companies or other entities:
- Gout and Uric Acid Society
( † Disclaimer: This search is powered by PubMed, a service of the U.S.
National Library of Medicine. PubMed is a third-party website with no
affiliation with Cleveland Clinic.)